Real-world treatment utilization in adults with chronic inflammatory demyelinating polyneuropathy in the United States
Cécile Blein, Chafic Karam, Clémence Arvin-Berod, Deborah Gelinas, Sergio Barrera-Sierra, Hashmath Ulla T. A. Syed, Charlotte Ward, Amit Goyal, Jeffrey Guptill · 2026
Read Real-world treatment utilization in adults with chronic inflammatory demyelinating polyneuropathy in the United States by Cécile Blein, Chafic Karam, Clémence Arvin-Berod, Deborah Gelinas, Sergio Barrera-Sierra, Hashmath Ulla T. A. Syed, Charlotte Ward, Amit Goyal, Jeffrey Guptill (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12896209.txt.
Description
Cécile Blein and co-authors mapped real world treatment for a long term nerve disease in the United States, in a study whose text is dated 2025. The disease weakens nerves over time, and care is hard because cases differ and some treatments are hard to get.
Using a large health database for 2016 to 2020, the team found 3,409 adults with the disease. About four in five got treatment in the year after their index date. Steroid drugs were most common, then a blood based immune treatment. Many patients used both at once, and even those on high steroid doses often stayed on added treatment. The pattern points to unmet need in care.
Catalog record
| CREATOR | Cécile Blein, Chafic Karam, Clémence Arvin-Berod, Deborah Gelinas, Sergio Barrera-Sierra, Hashmath Ulla T. A. Syed, Charlotte Ward, Amit Goyal, Jeffrey Guptill |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |